biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > how do the few longs feel about jd leaving you?

<< Previous

Bullboard Posts

Next >>

Comment by Comonreally42on Nov 10, 2022 1:49pm

128 Views

Post# 35089143

RE:RE:RE:RE:how do the few longs feel about jd leaving you?

Well you proved my point, no one willing to pay for it, no one. Valuation is pretty bang on.

Love to hear you measure success by clicks, to bad the grocery store doesnt accept clicks and I love how you blame the first CEO that shut that tap off on bad value, must be her fault, how can she not see the value ...Blah Blah Blah.

When I spoke to you on the phone, you werent that bright and a true windbag. Say Hi atthe AGM if you muscle up the courage to come.

Keep at it though JD, it seems to be working for you.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario